Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas-Reference-Cited by-同舟云学术

Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas

Published:2012-11 Issue:5 Volume:22 Page:668-682
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Lito Piro,Pratilas Christine A.,Joseph Eric W.,Tadi Madhavi,Halilovic Ensar,Zubrowski Matthew,Huang Alan,Wong Wai Lin,Callahan Margaret K.,Merghoub Taha,Wolchok Jedd D.,de Stanchina Elisa,Chandarlapaty Sarat,Poulikakos Poulikos I.,Fagin James A.,Rosen Neal

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference44 articles.

1. Feedback regulation of EGFR signalling: decision making by early and delayed loops;Avraham;Nat. Rev. Mol. Cell Biol.,2011

2. Recurrent BRAF mutations in Langerhans cell histiocytosis;Badalian-Very;Blood,2010

3. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity;Barretina;Nature,2012

4. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function;Basso;J. Biol. Chem.,2002

5. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma;Bollag;Nature,2010

Cited by 468 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRAF-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities;Clinical Colorectal Cancer;2024-09

2. Determinants of resistance and response to melanoma therapy;Nature Cancer;2024-07-17

3. Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer;Biomedicines;2024-06-10

4. Off-target autophagy inhibition by SHP2 allosteric inhibitors contributes to their antitumor activity in RAS-driven cancers;Journal of Clinical Investigation;2024-06-06

5. Triple Blockade of Oncogenic RAS Signaling Using KRAS and MEK Inhibitors in Combination with Irradiation in Pancreatic Cancer;International Journal of Molecular Sciences;2024-06-06